Impact of experimental colitis on hepatobiliary transporter expression and bile duct injury in mice

Background and Aims: The pathogenetic link between ulcerative colitis and sclerosing cholangitis (SC) is unclear. We hypothesized that colitis induces changes in bile composition via inflammation‐induced reduction of hepatobiliary transporter gene expression, ultimately resulting in cholestasis and bile duct injury.

[1]  R. Chapman,et al.  Etiopathogenesis of primary sclerosing cholangitis. , 2008, World journal of gastroenterology.

[2]  R. Sartor,et al.  Systemic uptake and intestinal inflammatory effects of luminal bacterial cell wall polymers in rats with acute colonic injury , 1988, Infection and immunity.

[3]  L. Tsui,et al.  Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis , 2003, Human Genetics.

[4]  A. Hofmann,et al.  The continuing importance of bile acids in liver and intestinal disease. , 1999, Archives of internal medicine.

[5]  V. Ling,et al.  Bile acid transport in sister of P-glycoprotein (ABCB11) knockout mice. , 2005, Biochemistry.

[6]  R. Yantiss,et al.  Induction of colitis in cftr-/- mice results in bile duct injury. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[7]  D. Granger,et al.  Impact of Dextran Sulfate Sodium Load on the Severity of Inflammation in Experimental Colitis , 2004, Digestive Diseases and Sciences.

[8]  J. Boyer,et al.  Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. , 1998, The Journal of clinical investigation.

[9]  K. Thummel,et al.  In vitro and in vivo drug interactions involving human CYP3A. , 1998, Annual review of pharmacology and toxicology.

[10]  R. Schmid,et al.  Disturbed bile secretion and cytochrome P450 function during the acute state of experimental colitis in rats. , 2000, Journal of hepatology.

[11]  A. Groen,et al.  Regulation of biliary lipid secretion by mdr2 P-glycoprotein in the mouse. , 1995, The Journal of clinical investigation.

[12]  R. Chapman,et al.  Immunopathogenesis of primary sclerosing cholangitis , 2005, Clinical reviews in allergy & immunology.

[13]  D. Adams,et al.  Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease , 2006, Nature Reviews Immunology.

[14]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[15]  K. Feingold,et al.  The Acute Phase Response Is Associated with Retinoid X Receptor Repression in Rodent Liver* , 2000, The Journal of Biological Chemistry.

[16]  L. Mayer.  Redefining autoimmunity. , 2003, Gastroenterology.

[17]  Y. Shitara,et al.  Down-regulation of hepatic transporters for BSP in rats with indomethacin-induced intestinal injury. , 2007, Biological & pharmaceutical bulletin.

[18]  G. Hooiveld,et al.  Upregulation of the multidrug resistance genes mrp1 and mdr1b and downregulation of the organic anion transporter mrp2 and bile salt transporter spgp in endotoxemic rat liver , 1998 .

[19]  A. Bergquist,et al.  Primary Sclerosing Cholangitis, Inflammatory Bowel Disease, and Colon Cancer , 2006, Seminars in liver disease.

[20]  C. Benz,et al.  [Primary sclerosing cholangitis]. , 2000, Der Internist.

[21]  E. Mazzon,et al.  Hepatocyte tight-junctional permeability is increased in rat experimental colitis. , 1997, Gastroenterology.

[22]  J. Vierling.  Animal models for primary sclerosing cholangitis. , 2001, Best practice & research. Clinical gastroenterology.

[23]  F. Lammert,et al.  Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver. , 2001, Gastroenterology.

[24]  R. Anari,et al.  Decreased Expression and Activity of P-GIycoprotein in Rat Liver During Acute Inflammation , 1998, Pharmaceutical Research.

[25]  M. Trauner,et al.  Mechanisms of Disease: mechanisms and clinical implications of cholestasis in sepsis , 2006, Nature Clinical Practice Gastroenterology &Hepatology.

[26]  K. Zatloukal,et al.  Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. , 2003, Gastroenterology.

[27]  T. Kawaguchi,et al.  Cholestasis with altered structure and function of hepatocyte tight junction and decreased expression of canalicular multispecific organic anion transporter in a rat model of colitis , 2000, Hepatology.

[28]  D. Adams,et al.  Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease , 2002, The Lancet.

[29]  J. Boyer,et al.  Expression of the bile salt export pump is maintained after chronic cholestasis in the rat. , 2000, Gastroenterology.

[30]  T. Wienker,et al.  Linkage between a new splicing site mutation in the MDR3 alias ABCB4 gene and intrahepatic cholestasis of pregnancy , 2007, Hepatology.

[31]  M. Chaluvadi,et al.  TLR4-dependent and -independent regulation of hepatic cytochrome P450 in mice with chemically induced inflammatory bowel disease. , 2009, Biochemical pharmacology.

[32]  R. Stauber,et al.  Inflammation‐induced cholestasis , 1999, Journal of gastroenterology and hepatology.

[33]  B. Stieger,et al.  Bile salt toxicity aggravates cold ischemic injury of bile ducts after liver transplantation in Mdr2+/− mice , 2006, Hepatology.

[34]  M. Piquette-Miller,et al.  Regulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in mice. , 2001, International immunopharmacology.

[35]  M. Piquette-Miller,et al.  Inflammatory Cytokines, but Not Bile Acids, Regulate Expression of Murine Hepatic Anion Transporters in Endotoxemia , 2002, Journal of Pharmacology and Experimental Therapeutics.

[36]  Y. Nakanuma,et al.  Pathology and immunopathology of immunoglobulin G4‐related sclerosing cholangitis: The latest addition to the sclerosing cholangitis family , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[37]  G. Tytgat,et al.  Effects of Ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene. , 1996, Gastroenterology.

[38]  M. Hadchouel,et al.  Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy , 1999, The Lancet.

[39]  T. Karlsen,et al.  Genetic epidemiology of primary sclerosing cholangitis. , 2007, World journal of gastroenterology.

[40]  M. Swain,et al.  Experimental Colitis Attenuates Development of Toxin-Induced Cholangitis in Rats , 2002, Digestive Diseases and Sciences.

[41]  D. Beier,et al.  Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents. , 1996, Gastroenterology.

[42]  N. LaRusso,et al.  The cholangiopathies: disorders of biliary epithelia. , 2004, Gastroenterology.

[43]  M. Trauner,et al.  MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes. , 2007, Seminars in liver disease.

[44]  G. Feierl,et al.  Time Course of Spontaneous Bacterial Translocation from Gastrointestinal Tract and Its Relationship to Intestinal Microflora in Conventionally Reared Infant Rats , 2001, Digestive Diseases and Sciences.

[45]  R. Berg.  Bacterial translocation from the gastrointestinal tract. , 1990, Trends in microbiology.

[46]  S. Kitajima,et al.  Tissue distribution of dextran sulfate sodium (DSS) in the acute phase of murine DSS-induced colitis. , 1999, The Journal of veterinary medical science.

[47]  K. Feingold,et al.  Repression of Farnesoid X Receptor during the Acute Phase Response* , 2003, The Journal of Biological Chemistry.